体力与认知活动与阿尔茨海默病神经影像生物标志物轨迹的关联
在Mayo Clinic老化研究队列中,纳入无痴呆的老年人,评估体力与认知活动与AD神经影像生物标志物纵向轨迹的关联。结果显示,较高的体力活动与FDG-PET下降较缓相关,较高的认知活动与PiB-PET上升较缓及FDG-PET下降较缓相关,但效应量较小。
要点
- 较高体力活动与FDG-PET代谢下降较缓相关。
- 较高认知活动与PiB-PET淀粉样蛋白沉积增加较缓相关。
- 认知活动亦与FDG-PET代谢下降较缓相关。
核心结论
- 体力活动与较少的突触功能障碍相关,认知活动与较少的突触功能障碍和较低的淀粉样蛋白负荷相关,但效应量较小。
研究设计与样本
- 在基于人群的Mayo Clinic老化研究中进行纵向分析,平均随访1.3-3.4年。
- 纳入基线年龄≥50岁、认知正常或轻度认知障碍的参与者,通过问卷评估基线前12个月的体力与认知活动。
- 采用线性混合效应模型分析活动综合评分与淀粉样蛋白沉积(PiB-PET centiloid)、tau负荷(tau-PET SUVR)和局部葡萄糖代谢减低(FDG-PET SUVR)年变化轨迹的关联,并调整年龄、性别、APOE ε4携带状态和医疗合并症。
- PiB-PET轨迹分析纳入1176名参与者(47%女性;平均[SD]年龄68.7[9.6]岁)。
- tau-PET轨迹分析纳入399名参与者(49%女性;平均[SD]年龄71.9[11.0]岁),FDG-PET轨迹分析纳入983名参与者(46%女性;平均[SD]年龄67.9[9.2]岁)。
主要发现
- 随访期间PiB-PET和tau-PET测量值增加(分别随访3.4[SD 4.0]年和1.3[SD 2.1]年),FDG-PET值在2.9[SD 3.5]年随访中下降。
- 较高的总体力活动(交互估计值0.0017;95% CI 0.0003-0.0031;p=0.021)和较高的中重度体力活动(交互估计值0.0015;95% CI 0.0001-0.0029;p=0.040)与FDG-PET随时间下降较缓相关。
- 较高的认知活动与PiB-PET随时间增加较缓(交互估计值-0.2253;95% CI -0.4437至-0.0070;p=0.043)和FDG-PET下降较小(交互估计值0.0015;95% CI 0.0001-0.0028;p=0.038)相关。
临床怎么用
- 在无痴呆的老年人中,鼓励体力活动可能有助于减缓突触功能障碍的影像学进展。
- 鼓励认知活动可能同时减缓淀粉样蛋白沉积和突触功能障碍的影像学进展,但效应量较小。
局限性
- 效应量较小,需进一步研究验证发现并阐明体力与认知活动和AD神经影像生物标志物之间的因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Engagement in physical and cognitive activities is associated with a decreased risk of mild cognitive impairment (MCI) and dementia, but the association with Alzheimer disease (AD) neuroimaging biomarkers is less clear. We thus examined associations of physical and cognitive activities with longitudinal trajectories of AD neuroimaging biomarkers among older adults free of dementia. METHODS: We conducted a longitudinal study within the population-based Mayo Clinic Study of Aging (mean follow-up durations 1.3-3.4 years). Participants were aged 50 years or older and were cognitively unimpaired or had MCI at baseline. Engagement in physical and cognitive activities during 12 months before baseline was assessed through questionnaires. Participants underwent AD neuroimaging biomarker assessments at 1 or more time points. We ran linear mixed-effect models to examine associations between physical and cognitive activity composite scores and trajectories of individual yearly change in amyloid deposition (Pittsburgh compound B [PiB]-PET centiloid), tau burden (tau-PET standardized uptake value ratio [SUVR]), and regional glucose hypometabolism (fluorodeoxyglucose [FDG]-PET SUVR), adjusted for age, sex, APOE ɛ4 carrier status, and medical comorbidity. RESULTS: We included 1,176 participants (47% female; mean [SD] age, 68.7 [9.6] years) for PiB-PET trajectories, 399 participants (49% female; mean [SD] age, 71.9 [11.0] years) for tau-PET trajectories, and 983 participants (46% female; mean [SD] age, 67.9 [9.2] years) for FDG-PET trajectories. PiB-PET and tau-PET measures increased during follow-up (3.4 [SD 4.0] and 1.3 [SD 2.1] years, respectively), whereas FDG-PET values decreased over 2.9 (SD 3.5) years of follow-up. Participants with higher total physical activity (interaction estimate 0.0017; 95% CI 0.0003-0.0031; p = 0.021) and higher moderate-to-vigorous physical activity (interaction estimate 0.0015; 95% CI 0.0001-0.0029; p = 0.040) had a less pronounced decrease in FDG-PET over time. Participants with higher cognitive activity experienced a less pronounced increase in PiB-PET (interaction estimate -0.2253; 95% CI -0.4437 to -0.0070; p = 0.043) and a smaller decrease in FDG-PET (interaction estimate 0.0015; 95% CI 0.0001-0.0028; p = 0.038) over time. DISCUSSION: Physical activity was associated with less synaptic dysfunction and cognitive activity with less synaptic dysfunction and lower amyloid burden over time, albeit effect sizes were small. Further research is needed to validate findings and clarify causal inference between physical and cognitive activities and AD neuroimaging biomarkers.
引用
- Krell-Roesch J, Syrjanen JA, Hansen AL, et al. Physical and Cognitive Activities and Trajectories of AD Neuroimaging Biomarkers: Longitudinal Analysis in the Mayo Clinic Study of Aging. Neurology. 2025. PMID: 41329905. doi:10.1212/WNL.0000000000214405
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。